Skip to main content
. 2023 May 15;29(6):1370–1378. doi: 10.1038/s41591-023-02347-y

Extended Data Table 1.

Summary of adverse events

graphic file with name 41591_2023_2347_Tab1_ESM.jpg

AE denotes adverse event, SAE denotes serious adverse event; frequency refers to patients reporting at least one adverse event (each patient is included once), treatment related include those classified as possibly, probably, or definitely related to DNX2401 + pembrolizumab.